Company ISR Immune System Regulation Holding AB (publ)
Equities
ISR
SE0008212195
Biotechnology & Medical Research
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ola Winqvist
CEO | Chief Executive Officer | 58 | 17/15/17 |
Jonas Winqvist
DFI | Director of Finance/CFO | 55 | 01/21/01 |
Johan Sjodahl
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 01/16/01 | |
Erik Kinnman
BRD | Director/Board Member | 66 | 01/22/01 |
Founder | 77 | 17/15/17 | |
Director/Board Member | 77 | 01/22/01 | |
Director/Board Member | - | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,008,951 | 48,981,535 ( 70.98 %) | 0 | 70.98 % |
Company contact information
ISR Immune System Regulation Holding AB
Retzius väg 11
171 65, Solna
+46 7 05 42 79 39
http://www.israb.se![address ISR Immune System Regulation Holding AB (publ)(ISR)](https://cdn.zonebourse.com/static/address/61747294.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+25.44% | 27.87B | |
-17.74% | 20.95B | |
-15.17% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |